Menu
Recruiting NCT02060565

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

Observational Chronic Liver Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Chronic Liver Disease. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease. a Retrospective and Prospective 20-year Follow-up.

Overview

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Detailed description

All consecutive patients with chronic liver disease will be followed during 20 years.

Primary outcome measures

  • Overall survival [Time frame: 20 years]
Secondary outcome measures (1)
  • Survival without liver complications [Time frame: 20 years]

Eligibility criteria

Inclusion criteria

  • chronic hepatitis C
  • chronic hepatitis B
  • alcohol liver disease
  • non alcoholic liver disease

Exclusion criteria

  • ascitis

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • Centre d'Investigation de la Fibrose hépatique Service Hépato-Gastroentérologie Hopital Ha — Pessac

Identifiers

NCT: NCT02060565 · HL V-0214

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗